CompoSecure (NASDAQ:CMPO) Releases Earnings Results, Beats Estimates By $0.06 EPS

CompoSecure (NASDAQ:CMPO - Get Free Report) posted its quarterly earnings results on Monday. The company reported $0.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.19 by $0.06, Zacks reports. CompoSecure had a negative return on equity of 14.87% and a negative net margin of 5.63%. The firm had revenue of $103.90 million during the quarter, compared to analyst estimates of $103.22 million.

CompoSecure Price Performance

Shares of CMPO traded up $0.19 during trading hours on Friday, hitting $12.80. The stock had a trading volume of 734,481 shares, compared to its average volume of 842,650. The firm has a market capitalization of $1.31 billion, a PE ratio of -29.09, a PEG ratio of 2.63 and a beta of 0.87. CompoSecure has a 12 month low of $5.98 and a 12 month high of $17.71. The stock has a fifty day moving average price of $11.00 and a 200 day moving average price of $13.71.

Insiders Place Their Bets

In other CompoSecure news, Director Resolute Compo Holdings Llc purchased 233,070 shares of the firm's stock in a transaction on Thursday, February 20th. The shares were acquired at an average cost of $16.57 per share, for a total transaction of $3,861,969.90. Following the completion of the transaction, the director now owns 879,963 shares of the company's stock, valued at approximately $14,580,986.91. The trade was a 36.03% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Adam Joseph Lowe sold 18,818 shares of CompoSecure stock in a transaction on Wednesday, March 12th. The stock was sold at an average price of $10.97, for a total transaction of $206,433.46. Following the transaction, the insider now owns 1,486,036 shares in the company, valued at $16,301,814.92. This represents a 1.25% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 34,340 shares of company stock valued at $430,701. Insiders own 74.99% of the company's stock.

Hedge Funds Weigh In On CompoSecure

A hedge fund recently raised its stake in CompoSecure stock. AQR Capital Management LLC grew its stake in CompoSecure, Inc. (NASDAQ:CMPO - Free Report) by 27.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 126,714 shares of the company's stock after buying an additional 27,064 shares during the quarter. AQR Capital Management LLC owned approximately 0.12% of CompoSecure worth $1,377,000 as of its most recent SEC filing. 37.56% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have issued reports on CMPO shares. Lake Street Capital decreased their target price on shares of CompoSecure from $18.00 to $15.00 and set a "buy" rating for the company in a report on Thursday, March 6th. Needham & Company LLC reaffirmed a "buy" rating and issued a $15.00 price objective on shares of CompoSecure in a research report on Tuesday. Finally, JPMorgan Chase & Co. decreased their price target on CompoSecure from $16.00 to $15.00 and set a "neutral" rating for the company in a research note on Thursday, March 6th. One research analyst has rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $16.19.

About CompoSecure

CompoSecure, Inc manufactures and designs metal, composite, and proprietary financial transaction cards in the United States and internationally. Its primary metal form factors include embedded, metal veneer lite, metal veneer, and full metal products. The company also offers Arculus Cold Storage Wallet, a three-factor authentication solution, which supports specific digital assets, including Bitcoin, Ethereum, non-fungible tokens and others.